Related references
Note: Only part of the references are listed.Distinct Signal Transduction Abnormalities and Erythropoietin Response in Bone Marrow Hematopoietic Cell Subpopulations of Myelodysplastic Syndrome Patients
Elena Spinelli et al.
CLINICAL CANCER RESEARCH (2012)
Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML
James Marvin et al.
BLOOD (2011)
Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor
Michele S. Redell et al.
BLOOD (2011)
Single-cell phospho-specific flow cytometric analysis demonstrates biochemical and functional heterogeneity in human hematopoietic stem and progenitor compartments
Kenneth D. Gibbs et al.
BLOOD (2011)
Dynamic Single-Cell Network Profiles in Acute Myelogenous Leukemia Are Associated with Patient Response to Standard Induction Therapy
Steven M. Kornblau et al.
CLINICAL CANCER RESEARCH (2010)
Granulocyte Colony-Stimulating Factor (G-CSF) Treatment of Childhood Acute Myeloid Leukemias That Overexpress the Differentiation-Defective G-CSF Receptor Isoform IV Is Associated With a Higher Incidence of Relapse
Stephanie Ehlers et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Functional Characterization of FLT3 Receptor Signaling Deregulation in Acute Myeloid Leukemia by Single Cell Network Profiling (SCNP)
David B. Rosen et al.
PLOS ONE (2010)
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
Phoenix A. Ho et al.
BLOOD (2009)
Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML
Jianbiao Zhou et al.
BLOOD (2009)
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates
Nikesh Kotecha et al.
CANCER CELL (2008)
Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance
Nadine N. Bewry et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT)
Yukiyasu Ozawa et al.
LEUKEMIA RESEARCH (2008)
Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group
Beverly J. Lange et al.
BLOOD (2008)
FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia
Jessica A. Pollard et al.
BLOOD (2006)
JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained
D. P. Steensma et al.
LEUKEMIA (2006)
Single cell profiling of potentiated phospho-protein networks in cancer cells
JM Irish et al.
CELL (2004)
Proteolytic conversion of STAT3α to STAT3γ in human neutrophils -: Role of granule-derived serine proteases
T Kato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells
PJ Real et al.
ONCOGENE (2002)
Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival
M Benekli et al.
BLOOD (2002)
Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia
S Meshinchi et al.
BLOOD (2001)
Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines
F Hayakawa et al.
ONCOGENE (2000)
Share Paper
